Astonea Labs Limited (BOM:544409)

India · Delayed Price · Currency is INR

157.00

+3.50 (2.28%)

At close: Mar 25, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
Manufacture and Sale of Drugs & Cosmetics	975.18M	801.91M	670.51M	300.57M	293.27M
Manufacture and Sale of Drugs & Cosmetics Growth	21.61%	19.60%	123.08%	2.49%	254.39%
Total	975.18M	801.91M	670.51M	300.57M	293.27M
Total Growth	21.61%	19.60%	123.08%	2.49%	254.39%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
India	860.73M	761.75M	670.51M	300.59M	-
India Growth	12.99%	13.61%	123.07%	-	-
Export	13.67M	8.09M	-	-	-
Export Growth	68.86%	-	-	-	-
Unallocated	97.57M	23.52M	-	-	-
Unallocated Growth	314.79%	-	-	-	-
Total	971.96M	793.37M	670.51M	300.59M	-
Total Growth	22.51%	18.32%	123.07%	-	-

Source: S&P Global Market Intelligence.